par Baselga, José;Greger, James J.G.;Abdel Azim, Hatem Hamdy
;Piccart-Gebhart, Martine
;de Azambuja, Evandro
;Dinh, Phuong
;Vuylsteke, Peter;Agbor‑Tarh, Dominique;Bradbury, Ian;Smith, Ian;Di Cosimo, Serena;Jackisch, Christian;Aktas, Bahriye;Eidtmann, Holger;Kim, Sung-Bae;Huang, Chiun Sheng;Hsieh, Ruey Kuen;Dreosti, Lydia
Référence Journal of clinical oncology, 31, 36, page (4504-4511)
Publication Publié, 2013
;Piccart-Gebhart, Martine
;de Azambuja, Evandro
;Dinh, Phuong
;Vuylsteke, Peter;Agbor‑Tarh, Dominique;Bradbury, Ian;Smith, Ian;Di Cosimo, Serena;Jackisch, Christian;Aktas, Bahriye;Eidtmann, Holger;Kim, Sung-Bae;Huang, Chiun Sheng;Hsieh, Ruey Kuen;Dreosti, LydiaRéférence Journal of clinical oncology, 31, 36, page (4504-4511)
Publication Publié, 2013
Article révisé par les pairs
| Titre: |
|
| Auteur: | Baselga, José; Greger, James J.G.; Abdel Azim, Hatem Hamdy; Piccart-Gebhart, Martine; de Azambuja, Evandro; Dinh, Phuong; Vuylsteke, Peter; Agbor‑Tarh, Dominique; Bradbury, Ian; Smith, Ian; Di Cosimo, Serena; Jackisch, Christian; Aktas, Bahriye; Eidtmann, Holger; Kim, Sung-Bae; Huang, Chiun Sheng; Hsieh, Ruey Kuen; Dreosti, Lydia |
| Informations sur la publication: | Journal of clinical oncology, 31, 36, page (4504-4511) |
| Statut de publication: | Publié, 2013 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Adult |
| Age Factors | |
| Aged | |
| Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects | |
| Antineoplastic Agents -- administration & dosage -- adverse effects | |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Breast Neoplasms -- chemistry -- drug therapy -- pathology | |
| Chemotherapy, Adjuvant | |
| Diarrhea -- chemically induced | |
| Drug Administration Schedule | |
| Drug Eruptions -- etiology | |
| Drug-Induced Liver Injury -- etiology | |
| Female | |
| Humans | |
| Incidence | |
| Logistic Models | |
| Middle Aged | |
| Neoadjuvant Therapy -- methods | |
| Paclitaxel -- administration & dosage | |
| Quinazolines -- administration & dosage -- adverse effects | |
| Receptor, ErbB-2 -- analysis | |
| Time Factors | |
| Tumor Markers, Biological -- analysis | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2013.50.9448 | |
| info:pii/JCO.2013.50.9448 | |
| info:scp/84894622956 | |
| info:pmid/24248687 |



